Kindred Biosciences, Inc. (NASDAQ: KIN) and Butterfly Network announce an affiliate relationship to make Butterfly’s state-of-the-art veterinary ultrasound tool, the iQ Vet, available to veterinarians in the United States.
Under the agreement, veterinarians will be able to purchase Butterfly iQ—a handheld, veterinary ultrasound device—through collaboration with their KindredBio representative.
“Butterfly is a leader in the creation of accessible and affordable ultrasound technology. We are excited to join them in advancing veterinary diagnostics with this state-of-the-art ultrasound device,” said Jenna Hahn, Vice President, Commercial, of KindredBio.
KindredBio, a biopharmaceutical company focused on saving and improving the lives of pets, has launched two products approved by the U.S. Food & Drug Administration in less than two years. In November, it launched Zimeta™ (dipyrone injection). The company also has a deep pipeline of therapeutics in development for dogs, cats and horses.
Last month, Butterfly Network announced the availability of Butterfly iQ Vet, an all-new handheld ultrasound device that only costs $1,999 plus subscription. iQ Vet brings the company’s groundbreaking ultrasound-on-chip™ technology to veterinarians and animals.
Butterfly iQ Vet is a single probe, smartphone-connected device that can scan animals of all sizes ranging from dogs and cats to horses. Ultrasound is a safe, non-invasive and painless diagnostic imaging modality. However, access to imaging for many veterinarians has been a challenge.
Recently, Butterfly iQ was voted as one of the best inventions of 2019 by Time magazine.
“With Butterfly iQ Vet, every animal hospital, clinic and mobile vet has access to a high-resolution device that will lead to earlier diagnosis, thereby improving medical care for all animals, large and small,” said Richard Markell, DVM, MRCVS, Director of Commercial Strategy, Veterinary, at Butterfly Network. “We are excited to partner with a company with a shared mission of advancing veterinary science.”
Zimeta™ is a trademark of Kindred Biosciences, Inc. in the United States and/or other countries. Ultrasound-On-Chip™ is a trademark of Butterfly Network Inc.
About Kindred Biosciences
Kindred Biosciences is a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy. The company’s strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for cats, dogs, and horses. The company has a deep pipeline of novel drugs and biologics in development across many therapeutic classes.
Visit http://kindredbio.com for more information.
About Butterfly Network
Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network has created the world’s first handheld, single-probe whole body ultrasound system, Butterfly iQ, making ultrasound technology universally accessible and affordable. Butterfly Network’s mission is to democratize healthcare for the 4.7 billion people around the world lacking access to medical imaging. Through their patented Ultrasound-On-Chip™ technology, Butterfly Network is paving the way for earlier detection and remote diagnosis of health conditions around the world.